Showing results (461-470 of 12,937) with videos related to

Sort By:
Pageof 1,294
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 15, 2021
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation with warfarin or edoxaban: An in-depth analysis from the ENGAGE AF-TIMI 48 randomized trialSarah E Nelson, Robert P Giugliano, Elliott M Antman, et al.
American Heart Journal|August 9, 2005
Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trialE Magnus Ohman, Frans Van de Werf, Elliott M Antman, et al.
Journal of the American College of Cardiology|November 3, 2001
ST segment resolution as a tool for assessing the efficacy of reperfusion therapyJ A de Lemos, E Braunwald
European Heart Journal|November 28, 2025
A polygenic risk score for peripheral artery disease and major adverse limb eventsSamer Al Said, Siddharth M Patel, Giorgio E M Melloni, et al.
Circulation|May 6, 2009
Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomesJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
The New England Journal of Medicine|June 5, 1980
Nifedipine therapy for coronary-artery spasm. Experience in 127 patientsE Antman, J Muller, S Goldberg, et al.
European Heart Journal|February 18, 2015
Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation†Michelle L O'Donoghue, Christian T Ruff, Robert P Giugliano, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2010
Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22Marc P Bonaca, David A Morrow, Eugene Braunwald, et al.
European Heart Journal|August 30, 2016
The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trialAlon Eisen, Christopher P Cannon, Michael A Blazing, et al.
Journal of the American College of Cardiology|June 15, 2007
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trialC Michael Gibson, Sabina A Murphy, Gilles Montalescot, et al.
Pageof 1,294